 BEIJING, Jan. 31, 2022 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, Nasdaq: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will be participating in two upcoming virtual investor conferences. 